The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Atovaquone and Proguanil-Global Market Insights and Sales Trends 2025
Synopsis
Atovaquone/Proguanil Hydrochloride is a dose combination of atovaquone and proguanil hydrochloride which acts as a blood schizonticide and also has activity against hepatic schizonts of Plasmodium falciparum.
The global Atovaquone and Proguanil market size is expected to reach US$ 191.2 million by 2029, growing at a CAGR of 6.1% from 2023 to 2029. The market is mainly driven by the significant applications of Atovaquone and Proguanil in various end use industries. The expanding demands from the Adult and Paediatric, are propelling Atovaquone and Proguanil market. 250 mg/100 mg, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 62.5mg/25mg segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Atovaquone and Proguanil market, driven by demand from China, the second largest economy with some signs of stabilising, the Atovaquone and Proguanil market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Atovaquone and Proguanil, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Atovaquone and Proguanil market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Atovaquone and Proguanil market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Atovaquone and Proguanil sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Atovaquone and Proguanil covered in this report include GSK, Glenmark, Mylan Pharmaceuticals and Hetero, etc.
The global Atovaquone and Proguanil market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GSK
Glenmark
Mylan Pharmaceuticals
Hetero
Global Atovaquone and Proguanil market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Atovaquone and Proguanil market, Segment by Type:
250 mg/100 mg
62.5mg/25mg
Global Atovaquone and Proguanil market, by Application
Adult
Paediatric
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Atovaquone and Proguanil manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Atovaquone and Proguanil in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Atovaquone/Proguanil Hydrochloride is a dose combination of atovaquone and proguanil hydrochloride which acts as a blood schizonticide and also has activity against hepatic schizonts of Plasmodium falciparum.
The global Atovaquone and Proguanil market size is expected to reach US$ 191.2 million by 2029, growing at a CAGR of 6.1% from 2023 to 2029. The market is mainly driven by the significant applications of Atovaquone and Proguanil in various end use industries. The expanding demands from the Adult and Paediatric, are propelling Atovaquone and Proguanil market. 250 mg/100 mg, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 62.5mg/25mg segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Atovaquone and Proguanil market, driven by demand from China, the second largest economy with some signs of stabilising, the Atovaquone and Proguanil market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Atovaquone and Proguanil, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Atovaquone and Proguanil market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Atovaquone and Proguanil market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Atovaquone and Proguanil sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Atovaquone and Proguanil covered in this report include GSK, Glenmark, Mylan Pharmaceuticals and Hetero, etc.
The global Atovaquone and Proguanil market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GSK
Glenmark
Mylan Pharmaceuticals
Hetero
Global Atovaquone and Proguanil market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Atovaquone and Proguanil market, Segment by Type:
250 mg/100 mg
62.5mg/25mg
Global Atovaquone and Proguanil market, by Application
Adult
Paediatric
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Atovaquone and Proguanil manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Atovaquone and Proguanil in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Atovaquone and Proguanil Market Overview
1.1 Atovaquone and Proguanil Product Overview
1.2 Atovaquone and Proguanil Market Segment by Type
1.2.1 250 mg/100 mg
1.2.2 62.5mg/25mg
1.3 Global Atovaquone and Proguanil Market Size by Type
1.3.1 Global Atovaquone and Proguanil Market Size Overview by Type (2018-2029)
1.3.2 Global Atovaquone and Proguanil Historic Market Size Review by Type (2018-2023)
1.3.3 Global Atovaquone and Proguanil Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Atovaquone and Proguanil Sales Breakdown by Type (2018-2023)
1.4.2 Europe Atovaquone and Proguanil Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Atovaquone and Proguanil Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Atovaquone and Proguanil Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Atovaquone and Proguanil Sales Breakdown by Type (2018-2023)
2 Global Atovaquone and Proguanil Market Competition by Company
2.1 Global Top Players by Atovaquone and Proguanil Sales (2018-2023)
2.2 Global Top Players by Atovaquone and Proguanil Revenue (2018-2023)
2.3 Global Top Players by Atovaquone and Proguanil Price (2018-2023)
2.4 Global Top Manufacturers Atovaquone and Proguanil Manufacturing Base Distribution, Sales Area, Product Type
2.5 Atovaquone and Proguanil Market Competitive Situation and Trends
2.5.1 Atovaquone and Proguanil Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Atovaquone and Proguanil Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Atovaquone and Proguanil as of 2022)
2.7 Date of Key Manufacturers Enter into Atovaquone and Proguanil Market
2.8 Key Manufacturers Atovaquone and Proguanil Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Atovaquone and Proguanil Status and Outlook by Region
3.1 Global Atovaquone and Proguanil Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Atovaquone and Proguanil Historic Market Size by Region
3.2.1 Global Atovaquone and Proguanil Sales in Volume by Region (2018-2023)
3.2.2 Global Atovaquone and Proguanil Sales in Value by Region (2018-2023)
3.2.3 Global Atovaquone and Proguanil Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Atovaquone and Proguanil Forecasted Market Size by Region
3.3.1 Global Atovaquone and Proguanil Sales in Volume by Region (2024-2029)
3.3.2 Global Atovaquone and Proguanil Sales in Value by Region (2024-2029)
3.3.3 Global Atovaquone and Proguanil Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Atovaquone and Proguanil by Application
4.1 Atovaquone and Proguanil Market Segment by Application
4.1.1 Adult
4.1.2 Paediatric
4.2 Global Atovaquone and Proguanil Market Size by Application
4.2.1 Global Atovaquone and Proguanil Market Size Overview by Application (2018-2029)
4.2.2 Global Atovaquone and Proguanil Historic Market Size Review by Application (2018-2023)
4.2.3 Global Atovaquone and Proguanil Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Atovaquone and Proguanil Sales Breakdown by Application (2018-2023)
4.3.2 Europe Atovaquone and Proguanil Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Atovaquone and Proguanil Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Atovaquone and Proguanil Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Atovaquone and Proguanil Sales Breakdown by Application (2018-2023)
5 North America Atovaquone and Proguanil by Country
5.1 North America Atovaquone and Proguanil Historic Market Size by Country
5.1.1 North America Atovaquone and Proguanil Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Atovaquone and Proguanil Sales in Volume by Country (2018-2023)
5.1.3 North America Atovaquone and Proguanil Sales in Value by Country (2018-2023)
5.2 North America Atovaquone and Proguanil Forecasted Market Size by Country
5.2.1 North America Atovaquone and Proguanil Sales in Volume by Country (2024-2029)
5.2.2 North America Atovaquone and Proguanil Sales in Value by Country (2024-2029)
6 Europe Atovaquone and Proguanil by Country
6.1 Europe Atovaquone and Proguanil Historic Market Size by Country
6.1.1 Europe Atovaquone and Proguanil Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Atovaquone and Proguanil Sales in Volume by Country (2018-2023)
6.1.3 Europe Atovaquone and Proguanil Sales in Value by Country (2018-2023)
6.2 Europe Atovaquone and Proguanil Forecasted Market Size by Country
6.2.1 Europe Atovaquone and Proguanil Sales in Volume by Country (2024-2029)
6.2.2 Europe Atovaquone and Proguanil Sales in Value by Country (2024-2029)
7 Asia-Pacific Atovaquone and Proguanil by Region
7.1 Asia-Pacific Atovaquone and Proguanil Historic Market Size by Region
7.1.1 Asia-Pacific Atovaquone and Proguanil Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Atovaquone and Proguanil Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Atovaquone and Proguanil Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Atovaquone and Proguanil Forecasted Market Size by Region
7.2.1 Asia-Pacific Atovaquone and Proguanil Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Atovaquone and Proguanil Sales in Value by Region (2024-2029)
8 Latin America Atovaquone and Proguanil by Country
8.1 Latin America Atovaquone and Proguanil Historic Market Size by Country
8.1.1 Latin America Atovaquone and Proguanil Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Atovaquone and Proguanil Sales in Volume by Country (2018-2023)
8.1.3 Latin America Atovaquone and Proguanil Sales in Value by Country (2018-2023)
8.2 Latin America Atovaquone and Proguanil Forecasted Market Size by Country
8.2.1 Latin America Atovaquone and Proguanil Sales in Volume by Country (2024-2029)
8.2.2 Latin America Atovaquone and Proguanil Sales in Value by Country (2024-2029)
9 Middle East and Africa Atovaquone and Proguanil by Country
9.1 Middle East and Africa Atovaquone and Proguanil Historic Market Size by Country
9.1.1 Middle East and Africa Atovaquone and Proguanil Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Atovaquone and Proguanil Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Atovaquone and Proguanil Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Atovaquone and Proguanil Forecasted Market Size by Country
9.2.1 Middle East and Africa Atovaquone and Proguanil Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Atovaquone and Proguanil Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 GSK
10.1.1 GSK Company Information
10.1.2 GSK Introduction and Business Overview
10.1.3 GSK Atovaquone and Proguanil Sales, Revenue and Gross Margin (2018-2023)
10.1.4 GSK Atovaquone and Proguanil Products Offered
10.1.5 GSK Recent Development
10.2 Glenmark
10.2.1 Glenmark Company Information
10.2.2 Glenmark Introduction and Business Overview
10.2.3 Glenmark Atovaquone and Proguanil Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Glenmark Atovaquone and Proguanil Products Offered
10.2.5 Glenmark Recent Development
10.3 Mylan Pharmaceuticals
10.3.1 Mylan Pharmaceuticals Company Information
10.3.2 Mylan Pharmaceuticals Introduction and Business Overview
10.3.3 Mylan Pharmaceuticals Atovaquone and Proguanil Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Mylan Pharmaceuticals Atovaquone and Proguanil Products Offered
10.3.5 Mylan Pharmaceuticals Recent Development
10.4 Hetero
10.4.1 Hetero Company Information
10.4.2 Hetero Introduction and Business Overview
10.4.3 Hetero Atovaquone and Proguanil Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Hetero Atovaquone and Proguanil Products Offered
10.4.5 Hetero Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Atovaquone and Proguanil Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Atovaquone and Proguanil Industrial Chain Analysis
11.4 Atovaquone and Proguanil Market Dynamics
11.4.1 Atovaquone and Proguanil Industry Trends
11.4.2 Atovaquone and Proguanil Market Drivers
11.4.3 Atovaquone and Proguanil Market Challenges
11.4.4 Atovaquone and Proguanil Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Atovaquone and Proguanil Distributors
12.3 Atovaquone and Proguanil Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
